Sansure Hepatitis B Viral Dna Quantitative Fluorecence Diagnostic Kit

We are esteemed manufacturer, supplier and exporter of Sansure Hepatitis B Viral DNA Quantitative Fluorecence Diagnostic Kit in Gurgaon, Haryana, India. Hepatitis B virus (HBV) infection remains a global public health problem with changing epidemiology due to several factors including vaccination policies ans migration. As estimated 257 million people are living with hepatitis B virus infection(defined as hepatitis B surface antigen positive). But there is still limited access to diagnosis and treatment of hepatitis B in many resource constrained settings. In 2015, of the 257 million people living with HBV infection, 9% (22 million) knew their diagnosis. Of those diagnosed, the global treatment coverage was only 8%(1.7 million). Many people are diagnosed only when they already have advanced liver disease. In May 2016, The World Health Assembly adopted the first "Global Health Sector Strategy on Viral Hepatitisi 2016-2020". The strategy has a vision of eliminating viral hepatitis as a public health problem and this is encapsulated in the global targets of reducing new viral hepatitis infections by 90% and reducing deaths due to viral hepatitis by 65% by 2030.